[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350720-105":59,"doc-detail-350720-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multiple-myeloma-complicating-breast-cancer-during-treatment-a-case-report","Multiple Myeloma Complicating Breast Cancer During Treatment - A Case Report","","Breast cancer is a leading malignant tumor threatening women’s health. The co-occurrence of breast cancer and multiple myeloma is clinically rare. A 56-year-old female with left breast invasive ductal carcinoma developed secondary IgA-λ multiple myeloma one year after breast cancer treatment, with fever and pancytopenia. She received targeted myeloma therapy and remained under continuous treatment. The report highlights the need to screen for secondary hematological malignancies during follow-up when atypical symptoms emerge.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multiple-myeloma-complicating-breast-cancer-during-treatment-a-case-report/350720/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multiple-myeloma-complicating-breast-cancer-during-treatment-a-case-report/350720.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the combination of breast cancer and multiple myeloma clinically rare?","Question",{"text":112,"@type":113},"The article notes that cases involving both breast cancer and multiple myeloma are relatively rare in routine clinical practice, and secondary multiple myeloma after breast cancer treatment remains infrequently documented globally.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What key symptoms and lab findings led to the multiple myeloma diagnosis in the case?",{"text":117,"@type":113},"The patient developed fever and pancytopenia. Further testing showed IgA-λ monoclonal immunoglobulin by immunofixation electrophoresis and myeloma cells (11%) in bone marrow smears, with abnormal plasma cells on immunophenotyping and biopsy consistent with multiple myeloma.",{"name":119,"@type":110,"acceptedAnswer":120},"What treatment approach was used after the diagnosis was confirmed?",{"text":121,"@type":113},"After confirmation, the patient was transferred to another hospital for targeted treatment of multiple myeloma and continued therapy through the follow-up period.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350720,1790316511,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Case Report  \nMultiple Myeloma Complicating Breast Cancer During Treatment: A Case Report  \nLijing Guo 1,†, Zhengshuo Jin 2,† and Yuehua Huang 2, *  \nReceived: 25 June 2026  \nRevised: 30 July 2026  \nAccepted: 6 August 2026  \nPublished: 10 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of General Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China; [glja02305@btch.edu.cn](glja02305@btch.edu.cn)  \n2 Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China; [jzsa03981@btch.edu.cn](jzsa03981@btch.edu.cn)  \n* [Correspondence: hyha00833@btch.edu.cn](Correspondence: hyha00833@btch.edu.cn)  \n† These authors are co-first authors of the article.  \nSimple Summary  \nBreast cancer is a leading malignant tumor threatening women’s health. The co-occurrence of breast cancer and multiple myeloma is clinically rare. We herein report a 56-year-old female patient with left breast invasive ductal carcinoma who developed secondary IgA-λ multiple myeloma one year after breast cancer treatment, presenting with fever and pancytopenia. She received targeted myeloma treatment and remains under continuous therapy. This case reminds clinicians to screen for secondary hematological malignancies in breast cancer patients with unexplained atypical symptoms during follow-up.  \nAbstract  \nResearch Background: Breast cancer is a malignant tumor that threatens women’s health. Among breast cancer patients, about 4.2% to 17% may suffer from multiple primary malignant neoplasms. Cases of patients suffering from both breast cancer and multiple myeloma are relatively rare in clinical practice. This paper reports one case of a patient who developed multiple myeloma during the treatment of breast cancer. Clinical Data: The patient was a 56-year-old female, admitted to hospital due to “fever for 4 days, one year after the treatment of left breast cancer”. The patient was diagnosed with left breast cancer (ypT1N1M0, HER2-overexpressing subtype) approximately one year prior to presentation. Following diagnosis, the patient was treated sequentially with TcbHP and THP chemotherapy regimens, and subsequently received local radiotherapy. The patient developed fever four days prior to admission. Further laboratory examinations revealed pancytopenia, positive IgA-λ-type monoclonal immunoglobulin by immunofixation electrophoresis, and myeloma cells accounting for 11% in bone marrow smears. Bone marrow immunophenotyping indicated abnormal plasma cells, and pathological results of bone marrow biopsy were consistent with multiple myeloma. The final diagnosis was breast cancer complicated with multiple myeloma. After confirmed diagnosis, the patient was transferred to another hospital for targeted treatment of multiple myeloma and has been receiving continuous treatment there up to the time of follow-up. Conclusions: For patients with breast cancer, if they develop bone pain, anemia, hypercalcemia or renal dysfunction that cannot be explained by tumor metastasis or conventional complications after surgery or during follow-up, clinicians should be alert to the possibility of second primary tumors.  \nKeywords: multiple myeloma; breast cancer; HER2-positive; chemotherapy; multiple primary malignant neoplasms  \n1. Background  \nFemale breast cancer represents the most frequently diagnosed malignancy among women globally. According to GLOBOCAN 2022 estimates, approximately 2.3 million new cases were diagnosed worldwide, accounting for nearly one-quarter of all new cancer diagnoses in females, with obvious geographic heterogeneity. High-income regions historically exhibit higher age-standardized incidence rates, while many middl","cbCaiiz6jBFoeKHx","https://ap.wps.com/l/cbCaiiz6jBFoeKHx","pdf",1029608,11,"English","# Case Report\n## Simple Summary\n## Abstract\n## Keywords\n## 1. Background\n## 2. Case Presentation\n### 2.1. General Information","[{\"question\":\"Why is the combination of breast cancer and multiple myeloma clinically rare?\",\"answer\":\"The article notes that cases involving both breast cancer and multiple myeloma are relatively rare in routine clinical practice, and secondary multiple myeloma after breast cancer treatment remains infrequently documented globally.\"},{\"question\":\"What key symptoms and lab findings led to the multiple myeloma diagnosis in the case?\",\"answer\":\"The patient developed fever and pancytopenia. Further testing showed IgA-λ monoclonal immunoglobulin by immunofixation electrophoresis and myeloma cells (11%) in bone marrow smears, with abnormal plasma cells on immunophenotyping and biopsy consistent with multiple myeloma.\"},{\"question\":\"What treatment approach was used after the diagnosis was confirmed?\",\"answer\":\"After confirmation, the patient was transferred to another hospital for targeted treatment of multiple myeloma and continued therapy through the follow-up period.\"}]","Multiple Myeloma Complicating Breast Cancer During Treatment - A Case Report | PDF",1790090774,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c1413f2534a8ac132eab70af63b67fd.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/427cfffda2496cd10bf953f0c3b011d0.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bfc42e32beb474454a193f685c433da.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/550d17636da19ab161a4cfa38c0e1db0.webp",980,1385]